Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
CytoMed Therapeutics Limited (GDTC) Weighted-Average Shares Outstanding (Diluted) data is not available.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Weighted-Average Shares Outstanding (Diluted) |
-- |
-- |
|
-- |
|
| Balance Sheet Financials | |
$2.50B |
|
$2.82B |
|
$2.92B |
|
$5.42B |
|
$945.88M |
|
$302.69M |
|
$302.69M |
|
$1.25B |
|
$4.17B |
|
$4.09B |
|
$4.17B |
|
11.94M |
|
| Cash Flow Statement Financials | |
$-1.27B |
|
$34.84M |
|
$744.66M |
|
$1.62B |
|
$1.13B |
|
$-492.02M |
|
$11.54M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|